AHNAK2 and nonpapillary renal cell carcinoma: This analysis provides strong evidence linking AHNAK2 to the pathogenesis of ccRCC through the dysregulation of fatty acid metabolism and the citrate cycle, as both pathways are known to be dysregulated in cancer, providing energy maintenance and cellular nutrition, although the exact mechanism is not known [65,66].